O-1602

• Target :

  Calcium Channel|||Cannabinoid Receptor

• Related Pathways :

  GPCR/G Protein|||Metabolism|||Membrane transporter/Ion channel

• Purity :

  0.9985

• Bioactivity :

  O-1602 is a novel GPR55 agonist, an atypical cannabinoid associated with the central nervous system and obesity, and is a candidate compound for the treatment of cystitis.O-1602 promotes hepatic steatosis through GPR55 and PI3 kinase / Akt / SREBP-1c signalling in mice.O-1602 induces, in a GPR3-independent manner, in Hep55B cells with elevated intracellular calcium.

• Smiles :

  CC1=C(C(O)=CC(O)=C1)[C@H]2[C@H](C(C)=C)CCC(C)=C2

• Molecular Formula :

  C17H22O2

• Molecular Weight :

  258.36

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  317321-41-8